Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200037/S018

ASSURE Wearable Cardioverter Defibrillator (WCD) System

Kestra Medical Technologies, Inc. · Decision date Mar 6, 2026

FDA DECISIONP200037/S018

What did the FDA approve?

FDA records P200037/S018 as a supplement to PMA P200037, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Mar 6, 2026.

FDA approval order statement

approval of software version 5.1.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Mar 6, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P200037/S018
Regulatory pathway
PMA supplement
Product code
MVK
Decision code
APPR
Decision date
Mar 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wearable automated external defibrillator.

Product code
MVK
FDA device class
3

For the original device and its historical approval scope, see PMA P200037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200037 · Original PMA

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  2. P200037/S017 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  3. P200037/S018 received

    Application receipt date recorded by FDA.

  4. P200037/S018 · FDA decision

    Normal 180 Day Track

  5. P200037/S019 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  6. P200037/S020 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator system (ASSURE system)

  7. P200037/S021 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  8. P200037/S022 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200037

Explore the linked device profile

Other records with product code MVK

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Manufacturing CorporationPMA supplementOct 6, 2026FDA
Zoll Manufacturing CorporationPMA supplementOct 5, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 29, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 9, 2026FDA
Zoll Manufacturing CorporationPMA supplementJul 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kestra Medical Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records